Return to homepagePandemic Pact

Development of CNS-permeant peptide antivirals to probe the molecular mechanism of the neurological manifestations of Long-COVID

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022

  • Funder

    Novo Nordisk Foundation

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Post acute and long term health consequences

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A